Related Experiment Videos
Seizures during barbiturate withdrawal: relation to blood level
W H Theodore1, R J Porter, R F Raubertas
1Clinical Epilepsy Section, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD 20892.
Annals of Neurology
|November 1, 1987
Summary
During phenobarbital (PB) withdrawal, seizure frequency may increase when PB blood levels drop below 20 mg/l. This finding is crucial for managing epilepsy patients undergoing medication adjustments.
Area of Science:
- Neurology
- Clinical Pharmacology
- Epilepsy Management
Background:
- Phenobarbital (PB) is a common antiepileptic drug.
- Withdrawal from PB can precipitate seizures in patients with epilepsy.
- Understanding optimal withdrawal strategies is critical for patient safety.
Purpose of the Study:
- To investigate the relationship between phenobarbital blood levels and seizure frequency during withdrawal.
- To identify specific PB concentration ranges associated with increased seizure activity.
- To inform clinical practice for safer antiepileptic drug tapering.
Main Methods:
- Prospective study of 21 patients undergoing phenobarbital or primidone withdrawal.
- Daily blood level monitoring of PB.
- Seizure frequency assessment via nursing staff and EEG-video telemetry.
- One-week baseline monitoring followed by five weeks of withdrawal observation.
Main Results:
- Seizure rates tended to be highest when PB blood levels were between 15 and 20 mg/l.
- No significant correlation found between PB withdrawal rate, other therapies, or initial PB level and seizure frequency ratios.
- Increased seizure frequency was most likely when PB blood levels fell below 20 mg/l.
Conclusions:
- Phenobarbital withdrawal may increase seizure risk as levels approach or fall below 20 mg/l.
- Close monitoring of PB blood levels during tapering is essential.
- This suggests a critical threshold for PB concentration during withdrawal to prevent seizure exacerbation.